Financials Suzhou Basecare Medical Corporation Limited

Equities

Market Closed - Hong Kong S.E. Other stock markets 01:38:42 28/06/2024 pm IST			5-day change	1st Jan Change
1.88 ^HKD	-3.59%		-4.08%	-20.00%

28/03	Suzhou Basecare Medical Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Suzhou Basecare Medical Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Capitalization ¹	1,493	901.1	584.2	478.6	-	-
Enterprise Value (EV) ¹	2.884	-355.5	584.2	478.6	478.6	478.6
P/E ratio	-10.9 x	-6.59 x	-3.05 x	-2.97 x	-4.07 x	-7.61 x
Yield	-	-	-	-	-	-
Capitalization / Revenue	13.9 x	6.4 x	2.81 x	1.51 x	1.15 x	0.95 x
EV / Revenue	13.9 x	6.4 x	2.81 x	1.51 x	1.15 x	0.95 x
EV / EBITDA	-11.4 x	-7.61 x	-3.36 x	-4.64 x	-5.32 x	-14.1 x
EV / FCF	-6.59 x	-	-1.57 x	-2.41 x	-3.49 x	-8.74 x
FCF Yield	-15.2%	-	-63.6%	-41.5%	-28.7%	-11.4%
Price to Book	0.84 x	0.57 x	0.42 x	0.39 x	0.43 x	0.45 x
Nbr of stocks (in thousands)	2,73,526	2,73,526	2,73,526	2,73,526	-	-
Reference price ²	5.459	3.294	2.136	1.750	1.750	1.750
Announcement Date	30/03/22	30/03/23	28/03/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	55.68	81.11	107.3	140.9	208	316	415.8	501.2
EBITDA ¹	-	-42.07	-131.4	-118.3	-173.9	-103	-90	-34
EBIT ¹	-	-48.63	-137.2	-126.1	-193.7	-123.8	-117.9	-61.77
Operating Margin	-	-59.95%	-127.87%	-89.51%	-93.14%	-39.17%	-28.36%	-12.32%
Earnings before Tax (EBT) ¹	-	-881.5	-125.7	-126.6	-196.3	-165	-118	-62
Net income ¹	-534	-877.1	-143.7	-122.7	-191.7	-160	-117	-62
Net margin	-958.96%	-1,081.33%	-133.88%	-87.06%	-92.17%	-50.63%	-28.14%	-12.37%
EPS ²	-	-5.100	-0.5000	-0.5000	-0.7000	-0.5900	-0.4300	-0.2300
Free Cash Flow ¹	-	-72.38	-226.8	-	-371.4	-198.8	-137.3	-54.74
FCF margin	-	-89.23%	-211.33%	-	-178.6%	-62.9%	-33.02%	-10.92%
FCF Conversion (EBITDA)	-	-	-	-	-	-	-	-
FCF Conversion (Net income)	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Announcement Date	17/09/20	30/03/21	30/03/22	30/03/23	28/03/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-	-	-
Net Cash position	-	161	1,490	1,257	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Free Cash Flow ¹	-	-72.4	-227	-	-371	-199	-137	-54.7
ROE (net income / shareholders' equity)	-	-	-14.4%	-7.42%	-12.8%	-9.9%	-10.4%	-0.37%
ROA (Net income/ Total Assets)	-	-350%	-13.4%	-6.85%	-10.4%	-9.7%	-7.6%	-4.3%
Assets ¹	-	250.7	1,076	1,790	1,839	1,649	1,539	1,442
Book Value Per Share ²	-	1.640	6.470	5.820	5.120	4.530	4.100	3.870
Cash Flow per Share	-	-0.3700	-0.7500	-	-	-	-	-
Capex ¹	-	8.09	28.9	-	104	10	20	30
Capex / Sales	-	9.97%	26.93%	-	50.11%	3.16%	4.81%	5.99%
Announcement Date	17/09/20	30/03/21	30/03/22	30/03/23	28/03/24	-	-	-

¹CNY in Million²CNY

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.75 CNY

Average target price

2.672 CNY

Spread / Average Target

+52.72%

	1st Jan change	Capi.
SUZHOU BASECARE MEDICAL CORPORATION LIMITED	-20.00%	6.59Cr
SONIC HEALTHCARE LIMITED	-18.02%	842.98Cr
RADNET, INC.	+69.46%	435.3Cr
DR. LAL PATHLABS LIMITED	+7.88%	277.58Cr
SYNLAB AG	-1.93%	263.74Cr
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-56.54%	173.91Cr
FLEURY S.A.	-16.69%	147.71Cr
METROPOLIS HEALTHCARE LIMITED	+17.87%	121.56Cr
DIAN DIAGNOSTICS GROUP CO.,LTD.	-49.60%	102.29Cr
ADICON HOLDINGS LIMITED	-21.78%	95Cr